France Christopher R, al'absi Mustafa, Ring Christopher, France Janis L, Brose John, Spaeth Donald, Harju Angie, Nordehn Glenn, Wittmers Lorentz E
Department of Psychology, Ohio University, 245 Porter Hall, Athens, OH 45701, USA.
Biol Psychol. 2005 Dec;70(3):168-74. doi: 10.1016/j.biopsycho.2005.01.012. Epub 2005 Jun 3.
This double blind, placebo-controlled study examined the effects of an opiate antagonist, naltrexone, on nociceptive flexion reflex (NFR) thresholds and subjective pain in individuals with and without a parental history of hypertension. Using a repeated measures design, NFR threshold was repeatedly assessed on two testing days after administration of either placebo or naltrexone. Immediately after NFR threshold was determined, participants rated the level of pain experienced during the preceding NFR assessment, and at the end of each session participants' electrocutaneous pain threshold was assessed. Two primary findings were obtained. First, individuals with a parental history of hypertension exhibited attenuated pain sensitivity. Second, endogenous opioid blockade was associated with increased pain ratings in women but with increased pain threshold in men. In sum, the present study did not support a direct involvement of the endogenous opioid system in the attenuated pain sensitivity observed in individuals at increased risk for hypertension.
这项双盲、安慰剂对照研究考察了阿片类拮抗剂纳曲酮对有或无高血压家族史个体的伤害性屈曲反射(NFR)阈值及主观疼痛的影响。采用重复测量设计,在给予安慰剂或纳曲酮后的两个测试日重复评估NFR阈值。在确定NFR阈值后,参与者立即对之前NFR评估期间经历的疼痛程度进行评分,并且在每个疗程结束时评估参与者的皮肤电疼痛阈值。获得了两个主要发现。第一,有高血压家族史的个体表现出疼痛敏感性减弱。第二,内源性阿片类物质阻断与女性疼痛评分增加相关,但与男性疼痛阈值增加相关。总之,本研究不支持内源性阿片系统直接参与高血压风险增加个体中观察到的疼痛敏感性减弱。